Every figure this model derived for BODYW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 3,332,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2026-06-30 |
| cash | 32,389,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 57,406,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 72,987,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 37,190,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 4,166,000 | InterestExpense |
2026-06-30 |
| ocf | 10,888,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 219,320,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 4,277,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up BODYW on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 13.76 |
| current ratio | 2.37 |
| current ratio reported | 0.79 |
| deferred revenue growth | -26.79 |
| dilution pct | 2.25 |
| fcf margin | 3.45 |
| interest cover | 4.31 |
| operating margin | 8.18 |
| owner earnings margin | 1.5 |
| revenue growth | -32.49 |
| revenue growth per share | -33.98 |
| roic | 44.41 |
| rule of 40 | -24.31 |
| sbc pct revenue | 1.95 |
What this model itself distrusts about BODYW's figures. Written by the derivation as it ran, not added afterwards.